Info

Totals: Phase 1-620, Phase 2 - 687, Phase 3 - 404, NDA awaiting - 167

Med Ad News July 2004 Supplement, 35-74.

Totals: Phase 1-620, Phase 2 - 687, Phase 3 - 404, NDA awaiting - 167

Med Ad News July 2004 Supplement, 35-74.

Fig. 1.19. R&D Productivity: Molecules in clinical trial (Copyright 2005, Thomson CenterWatch)

Source: © 2002 Thomson Center Watch all right reserved

Fig. 1.20. Product Pipeline (Adapted with permission from Engel Publishing Partners, Newtown Square, PA 2004. From Med Ad News July 2004 Suppl. 35-74.)

Biologicals □ Clinical PhaseD Approval Phase

2002-02 (n = 23) 1995-99 (n = 26) 1990-94 (n = 14) 1982-89 (n = 14)

2002-02 (n = 23) 1995-99 (n = 26) 1990-94 (n = 14) 1982-89 (n = 14)

Was this article helpful?

0 0
Outsourcing Survival Kit

Outsourcing Survival Kit

Tired Of Being Tied Down By Time? Wish You Could Achieve More And Earn More Within The Deadlines You Are Given? Want To Branch Out To Other Lucrative Areas Without Sacrificing Your Current Business?

Get My Free Ebook


Post a comment